TNF and Parkinson disease: In several of the PD and AD preclinical animal models in which targeted delivery of lenti-DN-TNF proved efficacious [18], [19], exogenous neurotoxic or inflammatory stimuli were administered as part of the paradigm to accelerate neuronal degeneration.